FDA Approves Erivedge For Most Common Type Of Skin Cancer

(CBS/AP) The FDA has approved a new drug called Erivedge to treat basal cell carcinoma, the most common form of skin cancer.


Federal regulators announced Monday the approval of the Erivedge pill, the first drug ever approved for treating basal cell carcinoma. Typical BCC treatments include outpatient procedures such as freezing or surgically removing the cancerous area.


More